The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Complementary medicines (4)
- COVID-19 (76)
- Advertising (65)
- COVID-19 vaccines (30)
- Medicine safety (27)
- Regulatory compliance (17)
- Labelling and packaging (8)
- Listed medicines (8)
- Non-prescription medicines (8)
- Prescription medicines (8)
- Therapeutic goods regulation (8)
- Vaping hub (8)
- Legislation (7)
- Assessed listed medicines (6)
- Safety (4)
- Manufacturing (3)
- Medical devices safety (3)
- Medicinal cannabis hub (3)
- Over the counter (OTC) medicines (3)
- Alert/Advisory (2)
- Scheduling (national classification system) (2)
- Advisory bodies and committees (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Blood safety (1)
- Compliance and enforcement hub (1)
- Import and export (1)
- In Vitro Diagnostic medical devices (IVDs) (1)
- Shortages (1)
- Sunscreens (1)
- Travelling with health products (1)
- Weight loss products (1)
Search
4 result(s) found, displaying 1 to 4
-
NewsBefore you take a weight loss supplement or medicine, there are things to consider.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
NewsThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Queensland-based individual for the alleged unlawful use of a prohibited representation and endorsement in advertising a listed complementary medicine.